1 terminated. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Graft Dysfunction: new trials by email Literature Review of Graft Dysfunction trials Research Report on Graft Dysfunction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TOP-Study (Tacrolimus Organ Perfusion): Treatment of Ischemia Reperfusion Injury in Marginal Organs With an ex Vivo Tacrolimus Perfusion Tacrolimus, HTK/Placebo - Terminal Liver Disease, Ischemia Reperfusion Injury | Phase 2 / Phase 3 | Terminated | Ludwig-Maximilians - University of Munich | 25 | 2011-10-01 | 2017-03-23 |
Cardiovascular Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Postoperative Complications (1) · Vascular Diseases (1)
Receptor, EphB4 (1) · Tacrolimus (1)
Ludwig-Maximilians - University of Munich (1)
Germany (1)
Karl-Walter Jauch, M.D. (1) · Martin Angele, M.D. (1) · Sebastian Pratschke, M.D. (1)